Goldman Sachs Group Inc Neogenomics Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,485,632 shares of NEO stock, worth $38.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,485,632
Previous 2,091,277 18.86%
Holding current value
$38.2 Million
Previous $29 Million 26.4%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$13.4 - $17.73 $5.28 Million - $6.99 Million
394,355 Added 18.86%
2,485,632 $36.7 Million
Q2 2024

Aug 13, 2024
SELL
$13.01 - $15.77 $2.94 Million - $3.57 Million
-226,181 Reduced 9.76%
2,091,277 $29 Million
Q1 2024

May 15, 2024
BUY
$14.06 - $16.79 $426,200 - $508,955
30,313 Added 1.33%
2,317,458 $36.4 Million
Q4 2023

Feb 13, 2024
SELL
$11.67 - $20.73 $2.1 Million - $3.73 Million
-179,991 Reduced 7.3%
2,287,145 $37 Million
Q3 2023

May 14, 2024
BUY
$12.15 - $17.85 $2.19 Million - $3.21 Million
179,991 Added 7.87%
2,467,136 $30.3 Million
Q3 2023

Nov 14, 2023
SELL
$12.15 - $17.85 $650,535 - $955,724
-53,542 Reduced 2.12%
2,467,136 $30.3 Million
Q2 2023

May 14, 2024
BUY
$14.1 - $19.83 $781,154 - $1.1 Million
55,401 Added 2.25%
2,520,678 $40.5 Million
Q2 2023

Aug 14, 2023
BUY
$14.1 - $19.83 $781,154 - $1.1 Million
55,401 Added 2.25%
2,520,678 $40.5 Million
Q1 2023

May 14, 2024
SELL
$9.09 - $19.45 $2.84 Million - $6.08 Million
-312,721 Reduced 11.26%
2,465,277 $42.9 Million
Q1 2023

May 11, 2023
SELL
$9.09 - $19.45 $2.84 Million - $6.08 Million
-312,721 Reduced 11.26%
2,465,277 $42.9 Million
Q4 2022

May 14, 2024
BUY
$6.45 - $12.07 $826,128 - $1.55 Million
128,082 Added 4.83%
2,777,998 $25.7 Million
Q4 2022

Feb 13, 2023
BUY
$6.45 - $12.07 $826,128 - $1.55 Million
128,082 Added 4.83%
2,777,998 $25.7 Million
Q3 2022

May 14, 2024
SELL
$7.86 - $12.91 $6.02 Million - $9.88 Million
-765,479 Reduced 22.41%
2,649,916 $22.8 Million
Q3 2022

Nov 10, 2022
SELL
$7.86 - $12.91 $6.02 Million - $9.88 Million
-765,479 Reduced 22.41%
2,649,916 $22.8 Million
Q2 2022

May 14, 2024
BUY
$7.06 - $13.97 $7.97 Million - $15.8 Million
1,128,250 Added 49.33%
3,415,395 $27.8 Million
Q2 2022

Aug 15, 2022
BUY
$7.06 - $13.97 $21 Million - $41.5 Million
2,973,739 Added 673.32%
3,415,395 $27.8 Million
Q1 2022

May 16, 2022
SELL
$12.15 - $35.28 $804,342 - $2.34 Million
-66,201 Reduced 13.04%
441,656 $5.37 Million
Q4 2021

Feb 14, 2022
BUY
$30.49 - $48.49 $8.21 Million - $13.1 Million
269,139 Added 112.74%
507,857 $17.3 Million
Q3 2021

Nov 10, 2021
BUY
$41.66 - $52.52 $9.94 Million - $12.5 Million
238,718 New
238,718 $11.5 Million

Others Institutions Holding NEO

# of Institutions
295
Shares Held
125M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.93B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email